- $678.26m
- $280.74m
- $455.04m
- 76
- 72
- 92
- 94
2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 482 | 239 | 392 | 509 | 455 |
Cost of Revenue | |||||
Gross Profit | 82.4 | -6.82 | 62.1 | 99.7 | 86.4 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 442 | 295 | 369 | 465 | 413 |
Operating Profit | 40.2 | -55.8 | 23 | 44.5 | 41.7 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 47.2 | -47.8 | 24.9 | 47.1 | 46 |
Provision for Income Taxes | |||||
Net Income After Taxes | 51.9 | -40.7 | 19.4 | 35.7 | 34.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 52 | -42.7 | 23.9 | 38.2 | 33.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 52 | -42.7 | 23.9 | 38.2 | 33.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.38 | -2.53 | 1.23 | 2.78 | 2.33 |
Dividends per Share | |||||
Special Dividends per Share |